Message from the MPCCC Executive
The real potential of impactful reform provides a positive outlook after a most challenging year. Rapid innovation across our health system in recent months has enabled work to continue across the landscape of our cancer engagement during the COVID-19 pandemic. Telehealth and tele-trials are growing themes that we anticipate will be a part of normal working capacitates in Victoria and elsewhere moving forward.
The MPCCC’s Executive group has worked to realise new collaborative cancer improvement opportunities across our own partnership and across the state including metropolitan-based cancer centres and regional healthcare providers. A substantial demonstration of this work has been the establishment and work of the Victorian COVID-19 Cancer Network (VCCN).
The VCCN is a joint initiative of the MPCCC and the Victorian Comprehensive Cancer Centre and provides support and advice to clinicians and healthcare services treating patients with cancer during the COVID-19 pandemic. Members of the MPCCC Executive group have worked tirelessly, beyond the scope and commitment of their clinical roles, to enable the success of the VCCN. Dr Haydon and Associate Professor Wong have key roles in chairing the work of the network, and Professor Segelov has dedicated time and expertise to ensuring the network recognises and addresses the needs of both the community and healthcare workers.
Bolstered by this successful collaboration, we anticipate that a whole-of-Victoria approach to innovating cancer care will become the norm. The focus of Victorian cancer research and health service partnerships like the MPCCC will be to ensure all people with cancer, no matter where they live or where they come from, have access to the best evidence-based treatment options. We intend to pursue this goal by continuing to engage statewide to improve linkages across sectors and disciplines.
More needs to be done to improve cancer care for Aboriginal and Torres Strait Islander members of our community. In addition, cultural and linguistic differences and socioeconomic and geographic barriers continue to challenge the delivery of equitable health care in Victoria. MPCCC is committed to systematically addressing and seeking to improve upon these inequities.
As we look to the future, we continue to build on MPCCC’s patient-centred programs, linking the latest genomic research to clinical care, addressing patient needs in real time by collecting outcome and experience data, improving access to oncology trials for people in regional Victoria, and efficiently including health professionals in the community to support hospital-based care. These programs centre on improving the availability and quality of efficient, evidence- and value-based cancer care.
Despite uncertainties about the future, there are more opportunities than ever before in the cancer sector to innovate and improve upon how people in our community are provided with care. This year has brought unanticipated challenges that have necessitated reform – reform that now provides much optimism for the year ahead.
Professor Melissa Southey
Chair, MPCCC Executive
Chair, Precision Medicine, Monash University